...
ttoo-img

T2 Biosystms Inc, Common Stock

TTOO

NAQ

$0.361

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$10.48M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.27M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.38
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.35 L
$8.38 H
$0.361

About T2 Biosystms Inc, Common Stock

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTTOOSectorS&P500
1-Week Return-30.58%-3.72%-0.05%
1-Month Return-29.22%-1.85%2.75%
3-Month Return-84.37%-11.4%7.4%
6-Month Return-92.96%-4.41%10.47%
1-Year Return-90.77%4.13%27.57%
3-Year Return-99.99%0.3%29.56%
5-Year Return-99.99%36.62%89.3%
10-Year Return-100%106.81%206.09%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue8.34M18.13M28.06M22.30M7.19M[{"date":"2019-12-31","value":29.71,"profit":true},{"date":"2020-12-31","value":64.62,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":79.5,"profit":true},{"date":"2023-12-31","value":25.64,"profit":true}]
Cost of Revenue16.76M21.28M20.70M21.14M15.36M[{"date":"2019-12-31","value":78.77,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":97.29,"profit":true},{"date":"2022-12-31","value":99.34,"profit":true},{"date":"2023-12-31","value":72.19,"profit":true}]
Gross Profit(8.43M)(3.15M)7.36M1.17M(8.17M)[{"date":"2019-12-31","value":-114.59,"profit":false},{"date":"2020-12-31","value":-42.83,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":15.85,"profit":true},{"date":"2023-12-31","value":-111.08,"profit":false}]
Gross Margin(101.12%)(17.37%)26.21%5.23%(113.58%)[{"date":"2019-12-31","value":-385.74,"profit":false},{"date":"2020-12-31","value":-66.28,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":19.94,"profit":true},{"date":"2023-12-31","value":-433.3,"profit":false}]
Operating Expenses43.63M38.21M50.33M56.68M41.49M[{"date":"2019-12-31","value":76.98,"profit":true},{"date":"2020-12-31","value":67.41,"profit":true},{"date":"2021-12-31","value":88.8,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":73.21,"profit":true}]
Operating Income(52.06M)(41.36M)(42.97M)(55.51M)(49.66M)[{"date":"2019-12-31","value":-5205800000,"profit":false},{"date":"2020-12-31","value":-4135600000,"profit":false},{"date":"2021-12-31","value":-4297300000,"profit":false},{"date":"2022-12-31","value":-5551000000,"profit":false},{"date":"2023-12-31","value":-4966400000,"profit":false}]
Total Non-Operating Income/Expense(14.30M)(10.95M)(12.74M)(12.88M)(6.12M)[{"date":"2019-12-31","value":-1429600000,"profit":false},{"date":"2020-12-31","value":-1094600000,"profit":false},{"date":"2021-12-31","value":-1274200000,"profit":false},{"date":"2022-12-31","value":-1288300000,"profit":false},{"date":"2023-12-31","value":-611500000,"profit":false}]
Pre-Tax Income(59.01M)(46.80M)(49.24M)(62.32M)(50.08M)[{"date":"2019-12-31","value":-5900600000,"profit":false},{"date":"2020-12-31","value":-4679800000,"profit":false},{"date":"2021-12-31","value":-4924100000,"profit":false},{"date":"2022-12-31","value":-6231700000,"profit":false},{"date":"2023-12-31","value":-5007700000,"profit":false}]
Income Taxes4.11M2.41M4.25M1.05M691.11K[{"date":"2019-12-31","value":96.52,"profit":true},{"date":"2020-12-31","value":56.65,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":24.75,"profit":true},{"date":"2023-12-31","value":16.25,"profit":true}]
Income After Taxes(63.11M)(49.21M)(53.49M)(63.37M)(50.77M)[{"date":"2019-12-31","value":-6311200000,"profit":false},{"date":"2020-12-31","value":-4920800000,"profit":false},{"date":"2021-12-31","value":-5349500000,"profit":false},{"date":"2022-12-31","value":-6337000000,"profit":false},{"date":"2023-12-31","value":-5076810500,"profit":false}]
Income From Continuous Operations(59.01M)(46.80M)(49.24M)(62.00M)(49.84M)[{"date":"2019-12-31","value":-5900600000,"profit":false},{"date":"2020-12-31","value":-4679800000,"profit":false},{"date":"2021-12-31","value":-4924100000,"profit":false},{"date":"2022-12-31","value":-6200300000,"profit":false},{"date":"2023-12-31","value":-4983600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(63.11M)(49.21M)(53.49M)(63.37M)(50.08M)[{"date":"2019-12-31","value":-6311200000,"profit":false},{"date":"2020-12-31","value":-4920800000,"profit":false},{"date":"2021-12-31","value":-5349500000,"profit":false},{"date":"2022-12-31","value":-6337000000,"profit":false},{"date":"2023-12-31","value":-5007700000,"profit":false}]
EPS (Diluted)(64.50)(23.00)(15.00)(14.36)(8.30)[{"date":"2019-12-31","value":-6450,"profit":false},{"date":"2020-12-31","value":-2300,"profit":false},{"date":"2021-12-31","value":-1500,"profit":false},{"date":"2022-12-31","value":-1436,"profit":false},{"date":"2023-12-31","value":-830,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TTOO
Cash Ratio 0.09
Current Ratio 0.40
Quick Ratio 0.24

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TTOO
ROA (LTM) -90.46%
ROE (LTM) -622.14%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TTOO
Debt Ratio Lower is generally better. Negative is bad. 1.65
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.65

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TTOO
Trailing PE NM
Forward PE NM
P/S (TTM) 1.07
P/B 14.50
Price/FCF NM
EV/R 3.20
EV/Ebitda NM
PEG NM

FAQs

What is T2 Biosystms Inc share price today?

T2 Biosystms Inc (TTOO) share price today is $0.361

Can Indians buy T2 Biosystms Inc shares?

Yes, Indians can buy shares of T2 Biosystms Inc (TTOO) on Vested. To buy T2 Biosystms Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TTOO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of T2 Biosystms Inc be purchased?

Yes, you can purchase fractional shares of T2 Biosystms Inc (TTOO) via the Vested app. You can start investing in T2 Biosystms Inc (TTOO) with a minimum investment of $1.

How to invest in T2 Biosystms Inc shares from India?

You can invest in shares of T2 Biosystms Inc (TTOO) via Vested in three simple steps:

  • Click on Sign Up or Invest in TTOO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in T2 Biosystms Inc shares
What is T2 Biosystms Inc 52-week high and low stock price?

The 52-week high price of T2 Biosystms Inc (TTOO) is $8.38. The 52-week low price of T2 Biosystms Inc (TTOO) is $0.35.

What is T2 Biosystms Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of T2 Biosystms Inc (TTOO) is

What is T2 Biosystms Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of T2 Biosystms Inc (TTOO) is 14.50

What is T2 Biosystms Inc dividend yield?

The dividend yield of T2 Biosystms Inc (TTOO) is 0.00%

What is the Market Cap of T2 Biosystms Inc?

The market capitalization of T2 Biosystms Inc (TTOO) is $10.48M

What is T2 Biosystms Inc’s stock symbol?

The stock symbol (or ticker) of T2 Biosystms Inc is TTOO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top